A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis (MS) in Finland between 2013 and 2022.

A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative condition similar to multiple sclerosis in humans. It also gave University of Michigan researchers a first ...

The world is full of nasty and deadly diseases, but some of the worst are the ones that turn your own body against you.

Switching from CD20 inhibitors to fumarate therapies reduces healthcare visits and infection-related costs, while controlling ...

The study estimated annual mortality rates for 5,797 individuals with MS compared with 28,807 controls with a similar age, ...